The Paul Ehrlich Foundation has awarded Mary-Claire King the €100,000 ($130,000) 2013 Paul Ehrlich Prize. King, a geneticist in the area of cancer and forensics, is a professor at the University of Washington.
She was awarded the prize for demonstrating that there is a genetic predisposition to breast cancer, specifically mutations found in the BRCA1 gene. The foundation said her efforts have a larger impact beyond breast cancer because she helped to show that genes are involved in complex, multifactorial diseases that also can be impacted by environmental and lifestyle factors.
Quest Diagnostics said that senior vice president and chief financial officer Robert Hagemann plans to leave the company at the end of May, and the firm is now searching internally and externally for a new CFO.